Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





X-Ray Imaging May Be Inadequate to Diagnose COVID-19

By HospiMedica International staff writers
Posted on 27 Apr 2020
A new study finds that among cases of confirmed COVID-19 patients, almost 90 % of chest x-rays read as normal or mild.

Researchers at Ohio State University (OSU, Columbus, USA), the State University of New York (SUNY, USA), and other institutions conducted a study involving 636 ambulatory patients (57% male) in New York who tested positive for SARS-CoV-2, and who also underwent a chest x-ray during March 2020. More...
Eleven board-certified radiologists--who knew they were reading images from COVID-19 patients--reviewed the chest x-rays and classified the findings as normal, mild, moderate, or severe disease. The patients ranged in age from 18 to 90, and over three-quarters were 30-70 years of age.

The results revealed that 58% of the chest x-rays were classified as normal. Of the 42% that did not read as normal, 195 demonstrated mild disease, 65 had moderate disease, and only five had severe disease. The most common findings were interstitial changes (23.7%) and ground glass opacities (19%). About a third of the findings were in the lower lobe, a quarter were multifocal, and about 21% were bilateral. Both effusions and lymphadenopathy were uncommon. The researchers noted that 74% of the original readings were classified as normal, but that 97 were changed to abnormal when read for the study. The study was published in the May 2020 issue of the Journal of Urgent Care Medicine.

“Providers ordering a chest x-ray in the outpatient setting should be aware that a patient with symptoms of COVID-19 may have a negative chest x-ray, and should manage the patient based on their symptoms,” said lead author Michael Weinstock, MD, of the OSU Wexner Medical Center. “Because most COVID-19 patients do not have severe illness, this is likely the population clinicians will be seeing, where their symptoms are severe enough to seek care. Doctor’s should not be reassured by a negative chest x-ray.”

The authors added that limitations to the data include its retrospective and observational nature, and that only a single chest x-ray series was obtained for each patient, making it impossible to determine if patients developed radiographic findings as the illness progressed. They also noted a lack of underlying health histories or basic chest x-rays to identify chronic pulmonary conditions. Finally, the radiologists were not blinded to the fact the patients had been diagnosed with COVID-19, which may have impacted their classification of the images.

Related Links:
Ohio State University
State University of New York



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.